tiprankstipranks
Advertisement
Advertisement

AU:CHM Stock Latest News

Chimeric Therapeutics Seeks ASX Quotation for Additional Shares
Company AnnouncementsChimeric Therapeutics Seeks ASX Quotation for Additional Shares
3d ago
CHM
Chimeric Therapeutics Reports Expiry of 45,000 Unexercised Options
PremiumCompany Announcements
Chimeric Therapeutics Reports Expiry of 45,000 Unexercised Options
3d ago
CHM
Chimeric Therapeutics Details Director Exit and Post-Consolidation Option Holdings
PremiumCompany Announcements
Chimeric Therapeutics Details Director Exit and Post-Consolidation Option Holdings
10d ago
CHM
Chimeric Therapeutics Board Member Eric Sullivan Retires
PremiumCompany Announcements
Chimeric Therapeutics Board Member Eric Sullivan Retires
11d ago
CHM
Chimeric Therapeutics Seeks Quotation for 1.77 Million New ASX Shares
PremiumCompany Announcements
Chimeric Therapeutics Seeks Quotation for 1.77 Million New ASX Shares
15d ago
CHM
Chimeric Therapeutics Launches Adviser-Led Strategic Review to Unlock Value
PremiumCompany AnnouncementsChimeric Therapeutics Launches Adviser-Led Strategic Review to Unlock Value
16d ago
CHM
Chimeric Therapeutics Seeks ASX Quotation for 733,333 New Shares
Premium
Company Announcements
Chimeric Therapeutics Seeks ASX Quotation for 733,333 New Shares
2M ago
CHM
Chimeric posts positive early CHM CDH17 CAR-T data in metastatic GI cancers
Premium
Company Announcements
Chimeric posts positive early CHM CDH17 CAR-T data in metastatic GI cancers
2M ago
CHM
Chimeric Therapeutics Seeks ASX Quotation for Additional Shares
PremiumCompany Announcements
Chimeric Therapeutics Seeks ASX Quotation for Additional Shares
2M ago
CHM
Chimeric Therapeutics Seeks ASX Quotation for New Share Issue
PremiumCompany Announcements
Chimeric Therapeutics Seeks ASX Quotation for New Share Issue
2M ago
CHM
Chimeric Therapeutics Plans Modest Share Placement on ASX
PremiumCompany Announcements
Chimeric Therapeutics Plans Modest Share Placement on ASX
2M ago
CHM
Chimeric Therapeutics Updates Capital Structure After Option Expiry
PremiumCompany Announcements
Chimeric Therapeutics Updates Capital Structure After Option Expiry
2M ago
CHM
Chimeric Therapeutics Issues 10 Million Long-Dated Unquoted Options
PremiumCompany AnnouncementsChimeric Therapeutics Issues 10 Million Long-Dated Unquoted Options
2M ago
CHM
Chimeric Therapeutics Issues New Shares Under Corporations Act Disclosure Exemption
Premium
Company Announcements
Chimeric Therapeutics Issues New Shares Under Corporations Act Disclosure Exemption
2M ago
CHM
Chimeric Therapeutics Seeks ASX Quotation for 6.9 Million New Shares
Premium
Company Announcements
Chimeric Therapeutics Seeks ASX Quotation for 6.9 Million New Shares
2M ago
CHM
Chimeric Therapeutics to List 733,333 New Shares on ASX
PremiumCompany Announcements
Chimeric Therapeutics to List 733,333 New Shares on ASX
3M ago
CHM
Chimeric Therapeutics Issues Unquoted Convertible Note Warrants
PremiumCompany Announcements
Chimeric Therapeutics Issues Unquoted Convertible Note Warrants
3M ago
CHM
Chimeric Therapeutics Issues New Unquoted Options and Convertible Notes
PremiumCompany Announcements
Chimeric Therapeutics Issues New Unquoted Options and Convertible Notes
3M ago
CHM
Chimeric Therapeutics Advances Lead CAR T Program and Reports Strong CORE-NK Trial Data
PremiumCompany Announcements
Chimeric Therapeutics Advances Lead CAR T Program and Reports Strong CORE-NK Trial Data
3M ago
CHM
Chimeric Therapeutics Finalises ASX Security Consolidation
PremiumCompany AnnouncementsChimeric Therapeutics Finalises ASX Security Consolidation
3M ago
CHM
Chimeric Therapeutics Secures Shareholder Approval for Capital Consolidation
Premium
Company Announcements
Chimeric Therapeutics Secures Shareholder Approval for Capital Consolidation
3M ago
CHM
Chimeric Therapeutics Wins Shareholder Backing for Capital Restructuring at EGM
Premium
Company Announcements
Chimeric Therapeutics Wins Shareholder Backing for Capital Restructuring at EGM
3M ago
CHM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >